September 11, 2025
We are thrilled to share that Digistain was hand selected by an expert panel of judges from EIT Health, AstraZeneca Spain, SERMAS and Hospital 12 de […]
June 25, 2025
It was an honour to take part in the recent Physics Deep Tech Showcase at Institute of Physics, hosted in partnership with the Venture Capital Unit […]
May 9, 2025
We were pleased to present at ASBRS2025 in Las Vegas, where we shared new clinical findings from the Digistain® programme. Our presentation included an abstract evaluating […]
January 29, 2025
We were honoured to recently host Professor Samuel Haryono from the Siloam Group Indonesia during his visit to the Digistain research lab at Imperial College London. […]
December 16, 2024
Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024. The first abstract presented data from Charing Cross Hospital […]
November 27, 2024
We’re thrilled to announce that Digistain® is now available to selected UK private patients, with reimbursement available though Bupa, WPA Health Insurance & Healix. Tim Woodman, Medical […]
November 24, 2024
We’re proud to share that our clinical validation study, published earlier this year in Breast Cancer Research and Treatment, has been recognised as one of the […]
September 4, 2024
We are thrilled to share the announcement today that Digistain® are 1 of 4 FINALISTS for the 2024 Nature Spin-off Prize Over 150 innovative technologies were […]
September 4, 2024
We are delighted to be in Abu Dhabi this week attending Abu Dhabi Global Healthcare Week with a UK delegation of NHS Organisations and digital health […]